Cargando…

Dedifferentiation and neuronal repression define familial Alzheimer’s disease

Identifying the systems-level mechanisms that lead to Alzheimer’s disease, an unmet need, is an essential step toward the development of therapeutics. In this work, we report that the key disease-causative mechanisms, including dedifferentiation and repression of neuronal identity, are triggered by...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldwell, Andrew B., Liu, Qing, Schroth, Gary P., Galasko, Douglas R., Yuan, Shauna H., Wagner, Steven L., Subramaniam, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673760/
https://www.ncbi.nlm.nih.gov/pubmed/33188013
http://dx.doi.org/10.1126/sciadv.aba5933
_version_ 1783611384829837312
author Caldwell, Andrew B.
Liu, Qing
Schroth, Gary P.
Galasko, Douglas R.
Yuan, Shauna H.
Wagner, Steven L.
Subramaniam, Shankar
author_facet Caldwell, Andrew B.
Liu, Qing
Schroth, Gary P.
Galasko, Douglas R.
Yuan, Shauna H.
Wagner, Steven L.
Subramaniam, Shankar
author_sort Caldwell, Andrew B.
collection PubMed
description Identifying the systems-level mechanisms that lead to Alzheimer’s disease, an unmet need, is an essential step toward the development of therapeutics. In this work, we report that the key disease-causative mechanisms, including dedifferentiation and repression of neuronal identity, are triggered by changes in chromatin topology. Here, we generated human induced pluripotent stem cell (hiPSC)–derived neurons from donor patients with early-onset familial Alzheimer’s disease (EOFAD) and used a multiomics approach to mechanistically characterize the modulation of disease-associated gene regulatory programs. We demonstrate that EOFAD neurons dedifferentiate to a precursor-like state with signatures of ectoderm and nonectoderm lineages. RNA-seq, ATAC-seq, and ChIP-seq analysis reveals that transcriptional alterations in the cellular state are orchestrated by changes in histone methylation and chromatin topology. Furthermore, we demonstrate that these mechanisms are observed in EOFAD-patient brains, validating our hiPSC-derived neuron models. The mechanistic endotypes of Alzheimer’s disease uncovered here offer key insights for therapeutic interventions.
format Online
Article
Text
id pubmed-7673760
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-76737602020-11-24 Dedifferentiation and neuronal repression define familial Alzheimer’s disease Caldwell, Andrew B. Liu, Qing Schroth, Gary P. Galasko, Douglas R. Yuan, Shauna H. Wagner, Steven L. Subramaniam, Shankar Sci Adv Research Articles Identifying the systems-level mechanisms that lead to Alzheimer’s disease, an unmet need, is an essential step toward the development of therapeutics. In this work, we report that the key disease-causative mechanisms, including dedifferentiation and repression of neuronal identity, are triggered by changes in chromatin topology. Here, we generated human induced pluripotent stem cell (hiPSC)–derived neurons from donor patients with early-onset familial Alzheimer’s disease (EOFAD) and used a multiomics approach to mechanistically characterize the modulation of disease-associated gene regulatory programs. We demonstrate that EOFAD neurons dedifferentiate to a precursor-like state with signatures of ectoderm and nonectoderm lineages. RNA-seq, ATAC-seq, and ChIP-seq analysis reveals that transcriptional alterations in the cellular state are orchestrated by changes in histone methylation and chromatin topology. Furthermore, we demonstrate that these mechanisms are observed in EOFAD-patient brains, validating our hiPSC-derived neuron models. The mechanistic endotypes of Alzheimer’s disease uncovered here offer key insights for therapeutic interventions. American Association for the Advancement of Science 2020-11-13 /pmc/articles/PMC7673760/ /pubmed/33188013 http://dx.doi.org/10.1126/sciadv.aba5933 Text en Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Caldwell, Andrew B.
Liu, Qing
Schroth, Gary P.
Galasko, Douglas R.
Yuan, Shauna H.
Wagner, Steven L.
Subramaniam, Shankar
Dedifferentiation and neuronal repression define familial Alzheimer’s disease
title Dedifferentiation and neuronal repression define familial Alzheimer’s disease
title_full Dedifferentiation and neuronal repression define familial Alzheimer’s disease
title_fullStr Dedifferentiation and neuronal repression define familial Alzheimer’s disease
title_full_unstemmed Dedifferentiation and neuronal repression define familial Alzheimer’s disease
title_short Dedifferentiation and neuronal repression define familial Alzheimer’s disease
title_sort dedifferentiation and neuronal repression define familial alzheimer’s disease
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673760/
https://www.ncbi.nlm.nih.gov/pubmed/33188013
http://dx.doi.org/10.1126/sciadv.aba5933
work_keys_str_mv AT caldwellandrewb dedifferentiationandneuronalrepressiondefinefamilialalzheimersdisease
AT liuqing dedifferentiationandneuronalrepressiondefinefamilialalzheimersdisease
AT schrothgaryp dedifferentiationandneuronalrepressiondefinefamilialalzheimersdisease
AT galaskodouglasr dedifferentiationandneuronalrepressiondefinefamilialalzheimersdisease
AT yuanshaunah dedifferentiationandneuronalrepressiondefinefamilialalzheimersdisease
AT wagnerstevenl dedifferentiationandneuronalrepressiondefinefamilialalzheimersdisease
AT subramaniamshankar dedifferentiationandneuronalrepressiondefinefamilialalzheimersdisease